Lanifibranor
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329504

CAS#: 927961-18-0

Description: Lanifibranor, also known as IVA-337, is a peroxisome proliferator-activated receptors (PPAR) agonist.


Price and Availability

Size
Price

25mg
USD 250
200mg
USD 1250
2g
USD 4850
Size
Price

50mg
USD 450
500mg
USD 1950
5g
USD 8950
Size
Price

100mg
USD 750
1g
USD 3250

Lanifibranor, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 329504
Name: Lanifibranor
CAS#: 927961-18-0
Chemical Formula: C19H15ClN2O4S2
Exact Mass: 434.0162
Molecular Weight: 434.909
Elemental Analysis: C, 52.47; H, 3.48; Cl, 8.15; N, 6.44; O, 14.71; S, 14.74


Synonym: Lanifibranor; IVA-337; IVA 337; IVA337.

IUPAC/Chemical Name: 4-(1-(1,3-Benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic acid

InChi Key: OQDQIFQRNZIEEJ-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)

SMILES Code: O=C(O)CCCC(N1S(=O)(C2=CC=C3N=CSC3=C2)=O)=CC4=C1C=CC(Cl)=C4


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Bruni C, Praino E, Allanore Y, Distler O, Gabrielli A, Iannone F,
Matucci-Cerinic M. Use of biologics and other novel therapies for the treatment
of systemic sclerosis. Expert Rev Clin Immunol. 2016 Dec 12:1-14. [Epub ahead of
print] PubMed PMID: 27899043.